Elevated pretreatment serum concentration of YKL‐40—An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer
I Thöm, B Andritzky, G Schuch, I Burkholder, L Edler… - Cancer, 2010 - Wiley Online Library
BACKGROUND: The glycoprotein YKL‐40 is synthesized both by cancer cells and by tumor‐
associated macrophages and plays a functional role in tumor progression. Consequently …
associated macrophages and plays a functional role in tumor progression. Consequently …
Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer.
I Thöm, B Andritzky, G Schuch, I Burkholder, L Edler… - Cancer, 2010 - europepmc.org
Background The glycoprotein YKL-40 is synthesized both by cancer cells and by tumor-
associated macrophages and plays a functional role in tumor progression. Consequently …
associated macrophages and plays a functional role in tumor progression. Consequently …
Elevated Pretreatment Serum Concentration of YKL-40-An Independent Prognostic Biomarker for Poor Survival in Patients With Metastatic Nonsmall Cell Lung Cancer
I Thom, B Andritzky, G Schuch, I Burkholder, L Edler… - core.ku.dk
BACKGROUND: The glycoprotein YKL-40 is synthesized both by cancer cells and by tumor-
associated macrophages and plays a functional role in tumor progression. Consequently …
associated macrophages and plays a functional role in tumor progression. Consequently …
Elevated pretreatment serum concentration of YKL‐40—An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer
I Thöm, B Andritzky, G Schuch, I Burkholder, L Edler… - Cancer, 2010 - infona.pl
BACKGROUND: The glycoprotein YKL‐40 is synthesized both by cancer cells and by tumor‐
associated macrophages and plays a functional role in tumor progression. Consequently …
associated macrophages and plays a functional role in tumor progression. Consequently …
[引用][C] Elevated Pretreatment Serum Concentration of YKL-40—An Independent Prognostic Biomarker for Poor Survival in Patients With Metastatic Nonsmall Cell Lung …
I THÖM, B ANDRITZKY, G SCHUCH… - Cancer, 2010 - pascal-francis.inist.fr
Elevated Pretreatment Serum Concentration of YKL-40—An Independent Prognostic
Biomarker for Poor Survival in Patients With Metastatic Nonsmall Cell Lung Cancer CNRS Inist …
Biomarker for Poor Survival in Patients With Metastatic Nonsmall Cell Lung Cancer CNRS Inist …
Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer
I Thöm, B Andritzky, G Schuch, I Burkholder… - Cancer, 2010 - pubmed.ncbi.nlm.nih.gov
Background The glycoprotein YKL-40 is synthesized both by cancer cells and by tumor-
associated macrophages and plays a functional role in tumor progression. Consequently …
associated macrophages and plays a functional role in tumor progression. Consequently …
Elevated Pretreatment Serum Concentration of YKL-40-An Independent Prognostic Biomarker for Poor Survival in Patients With Metastatic Nonsmall Cell Lung Cancer
I Thom, B Andritzky, G Schuch, I Burkholder, L Edler… - Cancer, 2010 - research.regionh.dk
BACKGROUND: The glycoprotein YKL-40 is synthesized both by cancer cells and by tumor-
associated macrophages and plays a functional role in tumor progression. Consequently …
associated macrophages and plays a functional role in tumor progression. Consequently …
Elevated pretreatment serum concentration of YKL‐40—An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer
I Thöm, B Andritzky, G Schuch, I Burkholder, L Edler… - Cancer, 2010 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> BACKGROUND:</jats: title><
jats: p> The glycoprotein YKL‐40 is synthesized both by cancer cells and by tumor …
jats: p> The glycoprotein YKL‐40 is synthesized both by cancer cells and by tumor …
[引用][C] Elevated Pretreatment Serum Concentration of YKL-40-An Independent Prognostic Biomarker for Poor Survival in Patients With Metastatic Nonsmall Cell Lung …
Cancer, 2010 - core.ku.dk
Elevated Pretreatment Serum Concentration of YKL-40-An Independent Prognostic Biomarker
for Poor Survival in Patients With Metastatic Nonsmall Cell Lung Cancer - Fitmum: Fitness for …
for Poor Survival in Patients With Metastatic Nonsmall Cell Lung Cancer - Fitmum: Fitness for …